Výsledky vyhledávání

Akademický článek

Effect of comprehensive geriatric assessment on hospitalizations in older adults with frailty initiating curatively intended oncologic treatment: The PROGNOSIS-RCT study.

Autor: Giger AW; Department of Geriatric Medicine, Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; OPEN, Open Patient Data Explorative Network, Odense University Hospital, J.B. Winsløws vej 9A, 5000 Odense, Denmark, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark. Electronic address: ann-kristine.weber.giger@rsyd.dk., Ditzel HM; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; OPEN, Open Patient Data Explorative Network, Odense University Hospital, J.B. Winsløws vej 9A, 5000 Odense, Denmark, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark; Department of Oncology, Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark., Ewertz M; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark., Ditzel H; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark; Department of Oncology, Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark., Jørgensen TL; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark; Department of Oncology, Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark., Pfeiffer P; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark; Department of Oncology, Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark., Lund C; Department of Medicine, Copenhagen University Hospital, Borgmester Ib Juuls vej 1, 2730 Herlev, Denmark; Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark; CopenAge, Copenhagen Center for Clinical Age research, University of Copenhagen, Blegdamsvej 3b, 2200 Copenhagen, Denmark., Ryg J; Department of Geriatric Medicine, Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark; Department of Clinical Research, University of Southern Denmark, Fionavej 36, 5230 Odense, Denmark; Academy of Geriatric Cancer Research (AgeCare), Odense University Hospital, J.B. Winsløws vej 4, 5000 Odense, Denmark.

Publikováno v: Journal of geriatric oncology [J Geriatr Oncol] 2024 Sep; Vol. 15 (7), pp. 101821. Date of Electronic Publication: 2024 Jul 20.

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Correction:VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6)

Autor: Elias, D., Vever, Henriette, Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.

Publikováno v: Elias, D, Vever, H, Lænkholm, A V, Gjerstorff, M F, Yde, C W, Lykkesfeldt, A E & Ditzel, H J 2020, ' Correction : VersicanV1 promotes proliferation and metastasis of hepatocellular carcinoma through the activation of EGFR–PI3K–AKT pathway (Oncogene, (2018), 37, 41, (5585-5586), 10.1038/s41388-018-0495-6) ', Oncogene, vol. 39, no. 10, pp. 2229-2230 . https://doi.org/10.1038/s41388-019-1096-8

Since the publication of this Erratum, the Authors noticed a further error in Fig. 1c. The same image was inserted twice next to each other (second row: PRKCA, image for RamR7 and TamR8) instead of the correct image for TamR8. The corrected Fig. 1c h

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::b051a8e3febdcb0bc7549e6995ab51da
https://findresearcher.sdu.dk:8443/ws/files/156519405/Correction.pdf

Zobrazit plný text záznamu

Distinct mechanisms of resistance to fulvestrant treatment dictate level of ER independence and selective response to CDK inhibitors in metastatic breast cancer

Autor: Kaminska K, Akrap N, Staaf J, Alves C, Ehinger A, Ebbesson A, Hedenfalk I, Beumers L, Veerla S, Harbst K, Ehmsen S, Borgquist S, Borg A, Perez-Fidalgo A, Ditzel H, Bosch A, Honeth G

Publikováno v: BREAST CANCER RESEARCH
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname

Background Resistance to endocrine treatment in metastatic breast cancer is a major clinical challenge. Clinical tools to predict both drug resistance and possible treatment combination approaches to overcome it are lacking. This unmet need is mainly

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::c13a0eef52ed5709e464fb2da225a626
https://www.fundanet.incliva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=15612

Zobrazit plný text záznamu

Correction to:Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138)

Autor: Elias, D., Vever, H., Lænkholm, A. V., Gjerstorff, M. F., Yde, C. W., Lykkesfeldt, A. E., Ditzel, H. J.

Publikováno v: Elias, D, Vever, H, Lænkholm, A V, Gjerstorff, M F, Yde, C W, Lykkesfeldt, A E & Ditzel, H J 2018, ' Correction to : Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy (Oncogene, (2015), 34, 15, (1919-1927), 10.1038/onc.2014.138) ', Oncogene, vol. 37, no. 41, pp. 5585–5586 . https://doi.org/10.1038/s41388-018-0495-6

Since the online publication of the above article, the authors have noted errors in subfigures 1c and 3b. Therefore, new images of the original immmunocytochemistry stainings have been obtained for Fig. 1c, and the Western blots for siRNA-mediated FY

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::0423a71859ac5b54355b59e1cccc56d5
https://findresearcher.sdu.dk:8443/ws/files/143489438/Correction_to_Gene_expression_profiling_identifies_FYN_as_an_important_molecule_in_tamoxifen_resistance_and_a_predictor_of_early_recurrence_in_patients_treated_with_endocrine_therapy.pdf

Zobrazit plný text záznamu

Akademický článek

SIOG2021-0100 - Predictive Value of Geriatric Oncology Screening and Geriatric Assessment in Older Patients with Solid Cancer: Preliminary Findings of a Prospective G8 Cohort Study (PROGNOSIS-G8)

Autor: Ditzel, H., Giger, A.K.W., Lund, C.M., Ditzel, H.J., Mohammadnejad, A., Pfeiffer, P., Ryg, J., Jørgensen, T.L., Ewertz, M.

Publikováno v: In Journal of Geriatric Oncology December 2021 12(8) Supplement 1:S54-S54

Zobrazit plný text záznamu

Akademický článek

Limited SP17 expression within tumors diminishes its therapeutic potential.

Autor: Gjerstorff, M. F.¹, Ditzel, H. J.^1,2

Publikováno v: Tissue Antigens. Dec2012, Vol. 80 Issue 6, p523-527. 5p. 2 Color Photographs, 1 Chart.

Zobrazit plný text záznamu

Akademický článek

An overview of the GAGE cancer/testis antigen family with the inclusion of newly identified members.

Autor: Gjerstorff, M. F.¹, Ditzel, H. J.^1,2 hditzel@health.sdu.dk

Publikováno v: Tissue Antigens. Mar2008, Vol. 71 Issue 3, p187-192. 6p. 1 Color Photograph, 2 Diagrams, 1 Chart.

Zobrazit plný text záznamu

SSX2-4 expression in early-stage non-small cell lung cancer

Autor: Greve, K B V, Pøhl, M, Olsen, K E, Nielsen, O, Ditzel, H J, Gjerstorff, M F

Publikováno v: Greve, K B V, Pøhl, M, Olsen, K E, Nielsen, O, Ditzel, H J & Gjerstorff, M F 2014, ' SSX2-4 expression in early-stage non-small cell lung cancer ', HLA, vol. 83, no. 5, pp. 344-349 . https://doi.org/10.1111/tan.12340

The expression of cancer/testis antigens SSX2, SSX3, and SSX4 in non-small cell lung cancers (NSCLC) was examined, since they are considered promising targets for cancer immunotherapy due to their immunogenicity and testis-restricted normal tissue ex

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3062::c60bea74ecd5be543da9c830dc486354
https://portal.findresearcher.sdu.dk/da/publications/afaa5b57-450d-476d-9801-d06b9350e5eb

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání